Hangzhou Huangsensheng Biotechnology

Hangzhou Huangsensheng Biotechnology is a Chinese biotechnology company focused on the research and development of innovative therapies for metabolic disorders, including diabetes and obesity. The company specializes in the discovery of small molecule drugs and peptide-based therapeutics aimed at addressing significant unmet medical needs in the metabolic health space. Based in Hangzhou, the firm leverages local R&D infrastructure to advance its early-stage pipeline through pre-clinical validation. Its business model centers on internal drug discovery and potential strategic collaborations within the domestic Chinese biopharmaceutical ecosystem.